Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia (scientific article)

Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22.

Q24536203

Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. Stanley Neuropathology Consortium

Q48583796

Ventricular enlargement in schizophrenia evaluated with computed tomographic scanning. Effects of gender, age, and stage of illness.

Q48865878

Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia

Q48884472

Genetic basis of schizophrenia

Q55064430

Genome-wide multipoint linkage analyses of multiplex schizophrenia pedigrees from the oceanic nation of Palau

Q58047111

Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q

Q58070633

Evidence for a putative bipolar disorder locus on 2p13-16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21-24, 13q32, 14q21 and 17q11-12

Q73181691

Evidence for a chromosome 2p13-14 schizophrenia susceptibility locus in families from Palau, Micronesia

Q77700483

Adenosine monophosphoramidase activity of Hint and Hnt1 supports function of Kin28, Ccl1, and Tfb3

Q24642988

Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases

Q24649493

Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins

Q27738382

Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex

Q28138248

Familial dementia caused by polymerization of mutant neuroserpin

Q28145741

Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival

Q28257331

The Histidine Triad Protein Hint Is Not Required for Murine Development or Cdk7 Function

Q28510492

Characterization of human cleaved N-CAM and association with schizophrenia

Q30757169

Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis

Q30788797

Analysis of matched mRNA measurements from two different microarray technologies

Q30830313

Gene expression profiling in the post-mortem human brain--no cause for dismay.

Q30996882

The histidine triad superfamily of nucleotide-binding proteins

Q33738439

Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia

Q33941953

Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging

Q33948419

Genomewide multipoint linkage analysis of seven extended Palauan pedigrees with schizophrenia, by a Markov-chain Monte Carlo method

Q34044838

Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse

Q34321656

Structural and functional sex differences in the human hypothalamus.

Q34354990

Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders.

Q35014684

Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders

Q35095860

Familial encephalopathy with neuroserpin inclusion bodies

Q35750194

Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse

Q35870821

Neuroserpin, an axonally secreted serine protease inhibitor

Q36803721

Influence of gender in schizophrenia as related to other psychopathological syndromes

Q37942891

Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia

Q38301403

Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study

Q38362304

Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays

Q39607930

Application of cDNA microarrays to examine gene expression differences in schizophrenia

Q43750661

Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia.

Q43940200

Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex

Q44045573

Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes

Q44889063

Sex differences in sex chromosome gene expression in mouse brain

Q46717400

Proteolysis of cell adhesion molecules by serine proteases: a role in long term potentiation?

Q48356814

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

schizophrenia

Q41112

P304

page(s)

1245-1255

P577

publication date

2004-06-01

P1433

published in

Neurochemical Research

Q15716728

P1476

title

Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia

P478

volume

Reverse relations

cites work (P2860)

Q29417078	A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype
Q27671245	A new crystal form of human histidine triad nucleotide-binding protein 1 (hHINT1) in complex with adenosine 5′-monophosphate at 1.38 Å resolution
Q44977420	Acute behavioral effects of nicotine in male and female HINT1 knockout mice
Q55380147	Altered Light Conditions Contribute to Abnormalities in Emotion and Cognition Through HINT1 Dysfunction in C57BL/6 Mice.
Q28485508	Altered functional protein networks in the prefrontal cortex and amygdala of victims of suicide
Q36661574	Altered gene expression in the superior temporal gyrus in schizophrenia
Q34994239	Analysis of whole genome biomarker expression in blood and brain
Q30884765	Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout mice associated with elevated plasma corticosterone level
Q33816462	Association of the histidine-triad nucleotide-binding protein-1 (HINT1) gene variants with nicotine dependence
Q42872711	Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate.
Q89204110	Chromosomal Conformations and Epigenomic Regulation in Schizophrenia
Q47920567	Comparative proteomic analysis of differentiation of mouse F9 embryonic carcinoma cells induced by retinoic acid
Q34299294	Cytosolic malate dehydrogenase regulates senescence in human fibroblasts.
Q46757055	Distribution and expression of protein kinase C interactive protein (PKCI/HINT1) in mouse central nervous system (CNS).
Q42517534	Effects of Hint1 deficiency on emotional-like behaviors in mice under chronic immobilization stress.
Q33503890	Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects
Q43105205	Expression, purification, crystallization and preliminary X-ray crystallographic analysis of human histidine triad nucleotide-binding protein 2 (hHINT2).
Q64057153	Gene Expression Profiles Associated with Brain Aging are Altered in Schizophrenia
Q34829319	Gene expression profiling in rodent models for schizophrenia
Q36535686	Gene expression profiling in schizophrenia and related mental disorders.
Q30480819	Genetic determinants of target and novelty-related event-related potentials in the auditory oddball response
Q37563079	Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations
Q34592420	Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder
Q47204896	HINT1 in Neuropsychiatric Diseases: A Potential Neuroplastic Mediator
Q36948351	Hint1 gene deficiency enhances the supraspinal nociceptive sensitivity in mice.
Q36617407	Implications for the practice of psychiatry
Q37312173	Is the histidine triad nucleotide-binding protein 1 (HINT1) gene a candidate for schizophrenia?
Q36083471	Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease
Q45051337	MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice.
Q35906525	Meta-analysis of sex differences in gene expression in schizophrenia
Q34994209	Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders
Q48840160	Molecular changes associated with hippocampal long-lasting depression induced by the serine protease subtilisin-A.
Q30490136	Physiogenomic analysis of localized FMRI brain activity in schizophrenia
Q26777276	Physiological and pathological roles of tissue plasminogen activator and its inhibitor neuroserpin in the nervous system
Q33342753	Protein expression in the nucleus accumbens of rats exposed to developmental vitamin D deficiency
Q38517137	Psychiatric disturbances regulate the innate immune system in CSF of conscious mice
Q48319544	Supersensitivity to amphetamine in protein kinase-C interacting protein/HINT1 knockout mice
Q37175279	Target identification for CNS diseases by transcriptional profiling.
Q51750311	The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases.
Q34659000	The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia.
Q39430418	The epigenomics of schizophrenia, in the mouse.
Q38089247	The search for peripheral disease markers in psychiatry by genomic and proteomic approaches
Q47171883	The serine protease inhibitor neuroserpin is required for normal synaptic plasticity and regulates learning and social behavior
Q50122927	Transcriptome alterations of prefrontal cortical parvalbumin neurons in schizophrenia
Q55044199	Variation in the malic enzyme 2 gene: implications for the pharmacogenomics of psychotic disorders.

P6179	Dimensions Publication ID	1024357185
P356	DOI	10.1023/B:NERE.0000023611.99452.47
P698	PubMed publication ID	15176481
P5875	ResearchGate publication ID	8531311